199 related articles for article (PubMed ID: 25492833)
1. Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.
Kent ST; Shimbo D; Huang L; Diaz KM; Viera AJ; Kilgore M; Oparil S; Muntner P
J Am Soc Hypertens; 2014 Dec; 8(12):898-908. PubMed ID: 25492833
[TBL] [Abstract][Full Text] [Related]
2. The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.
Shimbo D; Kent ST; Diaz KM; Huang L; Viera AJ; Kilgore M; Oparil S; Muntner P
J Am Soc Hypertens; 2014 Dec; 8(12):891-7. PubMed ID: 25492832
[TBL] [Abstract][Full Text] [Related]
3. Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services.
Dixon DL; Salgado TM; Luther JM; Byrd JB
J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1803-1809. PubMed ID: 31642596
[TBL] [Abstract][Full Text] [Related]
4. Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.
Dietrich E; Desai R; Garg M; Park H; Smith SM
J Clin Hypertens (Greenwich); 2020 Jan; 22(1):6-15. PubMed ID: 31873973
[TBL] [Abstract][Full Text] [Related]
5. Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States.
Desai R; Dietrich EA; Park H; Smith SM
Am J Hypertens; 2020 Nov; 33(11):999-1002. PubMed ID: 32930343
[TBL] [Abstract][Full Text] [Related]
6. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF
Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711
[TBL] [Abstract][Full Text] [Related]
7. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
Staessen JA; Beilin L; Parati G; Waeber B; White W
Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
Bookstaver DA; Hatzigeorgiou C
Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
[TBL] [Abstract][Full Text] [Related]
9. Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries.
Curtis JR; Laster AJ; Becker DJ; Carbone L; Gary LC; Kilgore ML; Matthews R; Morrisey MA; Saag KG; Tanner SB; Delzell E
J Clin Densitom; 2008; 11(4):568-74. PubMed ID: 18789740
[TBL] [Abstract][Full Text] [Related]
10. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
11. White Coat Hypertension Persistence in Children and Adolescents: The Pediatric Nephrology Research Consortium Study.
Miyashita Y; Hanevold C; Faino A; Scher J; Lande M; Yamaguchi I; Hernandez J; Acosta A; Weaver DJ; Thomas J; Kallash M; Ferguson M; Patel KN; South AM; Kelton M; Flynn JT
J Pediatr; 2022 Jul; 246():154-160.e1. PubMed ID: 35351534
[TBL] [Abstract][Full Text] [Related]
12. Office blood pressure versus ambulatory blood pressure measurement in childhood obesity.
van der Heijden LB; Groothoff JW; Feskens EJ; Janse AJ
BMC Pediatr; 2023 Apr; 23(1):205. PubMed ID: 37120521
[TBL] [Abstract][Full Text] [Related]
13. Comparison of office, home and ambulatory blood pressure measurements in hypertensive and suspected hypertensive SWICOS participants.
Radovanovic D; Muggli F; Bianchetti M; Gallino A; Parati G; Suter PM; Schoenenberger-Berzins R; Erne P; Schoenenberger AW
Blood Press; 2023 Dec; 32(1):2234496. PubMed ID: 37452435
[TBL] [Abstract][Full Text] [Related]
14. In the aftermath of SPRINT: further comparison of unattended automated office blood pressure measurement and 24-hour blood pressure monitoring.
Seidlerová J; Gelžinský J; Mateřánková M; Ceral J; König P; Filipovský J
Blood Press; 2018 Oct; 27(5):256-261. PubMed ID: 29566565
[TBL] [Abstract][Full Text] [Related]
15. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.
Parati G; Stergiou G; O'Brien E; Asmar R; Beilin L; Bilo G; Clement D; de la Sierra A; de Leeuw P; Dolan E; Fagard R; Graves J; Head GA; Imai Y; Kario K; Lurbe E; Mallion JM; Mancia G; Mengden T; Myers M; Ogedegbe G; Ohkubo T; Omboni S; Palatini P; Redon J; Ruilope LM; Shennan A; Staessen JA; vanMontfrans G; Verdecchia P; Waeber B; Wang J; Zanchetti A; Zhang Y;
J Hypertens; 2014 Jul; 32(7):1359-66. PubMed ID: 24886823
[TBL] [Abstract][Full Text] [Related]
16. White coat hypertension: addressing the 10 most important questions.
Kuritzky L
Curr Cardiol Rep; 2012 Dec; 14(6):678-83. PubMed ID: 22941589
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of otolaryngology claims to Medicare in 2012.
Bhattacharyya N; Lin HW
Otolaryngol Head Neck Surg; 2014 Nov; 151(5):802-4. PubMed ID: 25085322
[TBL] [Abstract][Full Text] [Related]
18. Utility of ambulatory blood pressure monitoring in the evaluation of elevated clinic blood pressures in children.
Halbach SM; Hamman R; Yonekawa K; Hanevold C
J Am Soc Hypertens; 2016 May; 10(5):406-12. PubMed ID: 27026571
[TBL] [Abstract][Full Text] [Related]
19. Patient Barriers and Facilitators to Ambulatory and Home Blood Pressure Monitoring: A Qualitative Study.
Carter EJ; Moise N; Alcántara C; Sullivan AM; Kronish IM
Am J Hypertens; 2018 Jul; 31(8):919-927. PubMed ID: 29788130
[TBL] [Abstract][Full Text] [Related]
20. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
